http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H107570-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_95eaed79dec59391549e8016815b3a8f |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198 |
| filingDate | 1996-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb245908f827a3863f2c0deccbdf8b54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b37024f0ae62df9220af2c779efe008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e4def6a7de1846497bc9fffb5c9d9b8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4714c19cf07c0aa257d54f7bdae11a56 |
| publicationDate | 1998-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H107570-A |
| titleOfInvention | Parkinson's disease prevention / treatment agent |
| abstract | (57) Abstract: A prophylactic / therapeutic agent for Parkinson's disease comprising a compound represented by the general formula (1) or a physiologically acceptable salt thereof and a dopamine precursor as active ingredients. Embedded image (R 1 and R 2 may be the same or different and each is a hydrogen atom, a halogen atom, R 3 is a hydrogen atom, an alkyl group or an acyl group, R 4 is a hydrogen atom, an alkyl group, an acyl group, an alkylsulfonyl group or A carboxyl group which may be esterified, Ar is a phenyl which may have 1 to 3 substituents selected from a halogen atom, an alkyl group, an alkoxy group, a nitro group, an amino group, an alkylamino group and a hydroxyl group; Or a nitrogen-containing monocyclic heteroaromatic ring group, m is a number of 1 to 5, and n is a number of 0 to 5. (Effect) It is useful for prevention and treatment of Parkinson's disease. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006043532-A1 |
| priorityDate | 1996-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 57.